1. Home
  2. XRTX vs SGD Comparison

XRTX vs SGD Comparison

Compare XRTX & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • SGD
  • Stock Information
  • Founded
  • XRTX 2011
  • SGD 2021
  • Country
  • XRTX Canada
  • SGD United States
  • Employees
  • XRTX N/A
  • SGD N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • SGD
  • Sector
  • XRTX Health Care
  • SGD
  • Exchange
  • XRTX Nasdaq
  • SGD Nasdaq
  • Market Cap
  • XRTX 4.4M
  • SGD 4.4M
  • IPO Year
  • XRTX N/A
  • SGD N/A
  • Fundamental
  • Price
  • XRTX $0.62
  • SGD $1.02
  • Analyst Decision
  • XRTX
  • SGD
  • Analyst Count
  • XRTX 0
  • SGD 0
  • Target Price
  • XRTX N/A
  • SGD N/A
  • AVG Volume (30 Days)
  • XRTX 154.7K
  • SGD 505.6K
  • Earning Date
  • XRTX 11-17-2025
  • SGD 11-14-2025
  • Dividend Yield
  • XRTX N/A
  • SGD N/A
  • EPS Growth
  • XRTX N/A
  • SGD N/A
  • EPS
  • XRTX N/A
  • SGD N/A
  • Revenue
  • XRTX N/A
  • SGD $4,970,752.00
  • Revenue This Year
  • XRTX N/A
  • SGD N/A
  • Revenue Next Year
  • XRTX N/A
  • SGD N/A
  • P/E Ratio
  • XRTX N/A
  • SGD N/A
  • Revenue Growth
  • XRTX N/A
  • SGD 2770.15
  • 52 Week Low
  • XRTX $0.52
  • SGD $0.65
  • 52 Week High
  • XRTX $1.79
  • SGD $3.03
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 47.57
  • SGD 50.07
  • Support Level
  • XRTX $0.52
  • SGD $0.74
  • Resistance Level
  • XRTX $0.61
  • SGD $1.23
  • Average True Range (ATR)
  • XRTX 0.05
  • SGD 0.12
  • MACD
  • XRTX 0.01
  • SGD 0.01
  • Stochastic Oscillator
  • XRTX 84.08
  • SGD 59.15

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

Share on Social Networks: